AINDEX
Markets

Cardio Diagnostics Holdings, Inc. (CDIOW)

CDIOWNASDAQ-CMBiotechnology: In Vitro & In Vivo Diagnostic Substances

$0.00960000

0.0000 (0.00%) today

Pre-market, Nov 17, 10:47 AM ET

No price history for this range
-38.54% 1D
Market cap
$16.6k
P/E
–
EPS, last 4 quarters
–
Dividend yield
–
Day range
–
52-week range
$0.00520000 to $0.0721
Average volume
–
Previous close
$0.00960000

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$4,000$3,000$5,000$4,000
Gross profit$4,000$3,000$5,000$4,000
Operating income-$1.46m-$1.78m-$1.50m-$1.73m
Net income-$1.47m-$1.79m-$1.50m-$1.73m

Last four quarters: revenue $16.0k, margin -40537.5%, free cash flow –

News

8 latest

The company

Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine ('Core Technology') for cardiovascular disease.

Sector
Health Care
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Exchange
NASDAQ-CM
Region
North America
Website
cdio.ai

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.